Diamond Hill Capital Management LLC Investment Advisor Purchases New Stake in Perrigo Company plc $PRGO
Diamond Hill Capital Management LLC Investment Advisor recently acquired a new stake in Perrigo Company plc, purchasing 391,340 shares valued at approximately $4.1 million. This acquisition gives Diamond Hill Capital Management a 0.28% ownership of Perrigo. Other institutional investors have also adjusted their holdings in Perrigo, which reported stronger-than-expected quarterly earnings and a dividend yield of 9.0%.
Perrigo Co. PLC stock outperforms competitors on strong trading day
Shares of Perrigo Co. PLC (PRGO) rallied 1.64% to $13.04 on Friday, despite a generally grim trading session for the broader market. The S&P 500 Index and Dow Jones Industrial Average both saw declines, making Perrigo's performance notable. This marked the stock's second consecutive day of gains.
Perrigo (NYSE:PRGO) Stock Price Down 4.4% - Should You Sell?
Perrigo's stock price dropped 4.4% to $12.28, despite beating quarterly earnings expectations with $0.50 EPS against a $0.39 consensus. Analysts maintain a "Hold" rating with an average target price of $19.33. The company declared a quarterly dividend of $0.29 per share, equating to an annualized 9.4% yield, and institutional investors hold a significant 95.91% stake.
Sei Investments Co. Sells 121,359 Shares of Perrigo Company plc $PRGO
Sei Investments Co. reduced its stake in Perrigo Company plc (NYSE:PRGO) by 43.3% in the first quarter, selling 121,359 shares and retaining 159,010 shares valued at approximately $1.7 million. Perrigo reported Q1 EPS of $0.50, exceeding analyst expectations, and revenue of $1.02 billion, while analysts maintain a "Hold" rating with an average price target of $19.33. The company also declared a quarterly dividend of $0.29 per share, representing a 9.1% annualized yield.
Perrigo Company PLC (PRGO) Stock News Today
This article provides current stock news for Perrigo Company PLC (PRGO), including its latest market performance with a 2.31% gain and a market cap of $1.78 billion. The page details an overview of the company's financial information, stock score, and analyst ratings. It indicates that more news, particularly regarding recent earnings, is expected soon.
Perrigo Q2 Earnings Call Highlights
Perrigo (PRGO) reported Q2 2026 results, exceeding earnings expectations despite a decline in sales due to soft consumer self-care categories and retailer inventory reductions. The company maintained its full-year outlook, anticipating improved category trends and market-share gains in the second half. Management emphasized continued share gains in both the U.S. and Europe, driven by products like Opill and Compeed, and is strategically reviewing its infant formula and oral care businesses.
Perrigo Q2 Earnings Call Highlights
Perrigo (PRGO) reported Q2 2026 results exceeding earnings expectations despite a sales decline due to soft consumer self-care categories and retailer inventory reductions. The company maintained its full-year outlook, citing improving trends, market-share gains, and expected second-half contributions from innovation. Perrigo also reduced debt through divestitures and is reviewing strategic options for its infant formula and oral care businesses.
Perrigo Company Plc Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next
Perrigo Company Plc recently exceeded its earnings expectations. This article will discuss what analysts anticipate for the company's future performance following this positive earnings report.
Perrigo Company plc (PRGO) Stock Forecasts
This article provides an analyst report from Morningstar on Perrigo Company plc (PRGO), a consumer healthcare product manufacturer. The report highlights the company's recent infant formula recovery, which was met with excitement despite ongoing uncertainties. Perrigo specializes in private-label consumer health goods sold through major retailers in North America.
Results: Perrigo Company plc Exceeded Expectations And The Consensus Has Updated Its Estimates
Perrigo Company plc (NYSE:PRGO) shareholders saw a 27% increase in their stake following better-than-expected quarterly profits, despite revenues meeting analyst forecasts. While analysts reconfirmed revenue estimates for 2026, they significantly increased per-share loss predictions, though the consensus price target remained unchanged at US$16.50. The company's revenue is expected to decline by 4.1% annually through 2026, underperforming the industry's projected 9.2% annual growth.
Quantinno Capital Management LP Sells 168,471 Shares of Perrigo Company plc $PRGO
Quantinno Capital Management LP reduced its stake in Perrigo Company plc by 25.4%, selling 168,471 shares and retaining 493,866 shares valued at approximately $5.3 million. Despite a decline in sales, Perrigo's latest quarterly earnings beat expectations, and the company reaffirmed its fiscal 2026 EPS guidance and declared a quarterly dividend. Analysts currently maintain a consensus "Hold" rating for the stock with a price target of $19.33.
Perrigo Company Delivers 42.9% Q2 2026 Upside, Revenue Down 3%
Perrigo Company plc reported Q2 2026 adjusted earnings of $0.50 per share, significantly exceeding analysts' $0.35 forecast by 42.9%. Despite this strong earnings beat, the company's revenue declined by 3.2% year-over-year to $1.02 billion, with organic net sales falling by 1.3%. Management provided a full-year 2026 EPS guidance of $2.00 to $2.30, indicating a focus on continued cost management amidst revenue pressures.
Perrigo Stock Rises 23% as Q2 Earnings & Sales Beat Estimates
Perrigo (PRGO) reported strong second-quarter 2026 results, with All In adjusted earnings per share of 50 cents significantly beating the Zacks Consensus Estimate of 31 cents. Despite a decline in All In net sales to $1.02 billion, this still marginally surpassed the $1 billion consensus. The positive earnings surprise led to a 23% surge in PRGO stock, contrasting with the industry's year-to-date decline.
Perrigo Company plc Q2 2026 Earnings Call Summary
Perrigo Company plc reported a 3.1% core net sales decline in Q2 2026 due to temporary category softness and retailer destocking, but gained market share in key segments and maintained full-year guidance. The company is focusing on strategic portfolio simplification, improving operational efficiency, and leveraging its diverse geographic mix. Key initiatives include the "Three-S" plan, divestment of Dermacosmetics, and strategic reviews of Infant Formula and Oral Care businesses, alongside increasing investment in Opill.
Earnings Flash (PRGO) Perrigo Company Plc Posts Q2 Adjusted EPS $0.50 per Share, Vs. FactSet Est of $0.34
Perrigo Company Plc (PRGO) announced its second-quarter adjusted EPS of $0.50 per share, significantly exceeding the FactSet estimate of $0.34 per share. This financial beat indicates a stronger performance than anticipated by analysts for the quarter.
Perrigo Company plc 2026 Q2 - Results - Earnings Call Presentation (NYSE:PRGO)
Perrigo Company plc (NYSE:PRGO) released its Q2 2026 earnings call presentation on August 5, 2026. The company reported an EPS of $0.50, beating estimates by $0.15, and revenue of $1.02 billion, exceeding expectations by $12.65 million despite a 3.17% year-over-year decrease. This presentation provides details discussed during their earnings call.
Perrigo Company plc (PRGO) Stock Price | Live Quotes & Charts | NYSE
This page provides live quotes and charts for Perrigo Company plc (PRGO) stock on the NYSE. It shows the current stock price of $13.12, a gain of $2.34 (21.69%), but notes that prices are delayed. The article also includes sections for analyst ratings, though none are currently available, and mentions that earnings information for Perrigo Company plc is not yet provided.
Perrigo Company Delivers 42.9% Q2 2026 Upside, Revenue Down 3%
Perrigo Company plc reported strong Q2 2026 adjusted earnings of $0.50 per share, significantly beating analyst expectations, despite a 3.2% decrease in revenue to $1.02 billion. The earnings outperformance was attributed to operational efficiency and cost management rather than top-line growth, with organic net sales declining 1.3%. The market reacted with muted trading, suggesting investor concerns about the sustainability of margin-driven beats amidst persistent revenue declines, particularly in its Self Care segment.
Perrigo Company Releases Q2 2026 Financial Results
Perrigo Company plc announced Q2 2026 financial results, exceeding Wall Street expectations for earnings per share despite a decline in sales. The company reported adjusted EPS of $0.50, significantly above the $0.35 forecast, on revenue of $1.02 billion. Perrigo projects full-year 2026 adjusted earnings per share between $2.00 and $2.30.
Perrigo (PRGO) Reports Q2 Earnings: What Key Metrics Have to Say
Perrigo (PRGO) reported Q2 2026 revenue of $1.02 billion, a 3.2% decrease year-over-year, and an EPS of $0.50, down from $0.57 in the prior year. Despite the revenue decrease, the company surpassed Zacks Consensus Estimates for both revenue and EPS. Key metric performance, including Net Sales for Self Care, Specialty Sciences, All Other, and Infant Formula, indicates a mixed financial quarter for Perrigo.
Perrigo Company Plc (PRGO) Stock Analysis: A Deep Dive Into Its 54.49% Potential Upside
Perrigo Company Plc (PRGO) presents a potential investment opportunity with an analyst-projected upside of 54.49%, despite recent declines from its 52-week high and current financial challenges. The company, a healthcare sector stalwart known for OTC health and wellness products, trades near its 52-week low. While facing revenue decline and a negative return on equity, its low forward P/E ratio and high dividend yield (albeit with a high payout ratio) suggest undervaluation, making it a consideration for value investors who are prepared to monitor its operational improvements.
Perrigo Co. PLC stock outperforms competitors on strong trading day
Perrigo Co. PLC (PRGO) saw its stock rise by 5.64% to $10.68 on Monday, outperforming the broader market, which also experienced a strong trading session. This increase broke a two-day losing streak for the company's shares. The S&P 500 Index and Dow Jones Industrial Average both posted significant gains on the same day.
Empowered Funds LLC Buys 150,438 Shares of Perrigo Company plc $PRGO
Empowered Funds LLC significantly increased its stake in Perrigo Company plc by 41.6% in the first quarter, purchasing an additional 150,438 shares. This brings their total holdings to 511,872 shares, valued at approximately $5.5 million. The article notes that while Perrigo reported earnings per share above estimates, revenue fell short, and analysts maintain a consensus "Hold" rating for the stock.
Dimensional Fund Advisors LP Has $70.53 Million Stock Position in Perrigo Company plc $PRGO
Dimensional Fund Advisors LP significantly reduced its stake in Perrigo Company plc by 11.3% in the first quarter, selling 838,228 shares, but still holds 6.57 million shares valued at approximately $70.5 million. Perrigo's recent quarterly earnings beat estimates with $0.43 EPS but revenue declined by 7.2% year-over-year to $841.8 million, missing consensus. Despite a consensus "Hold" rating and a target price of $19.33, the stock recently traded near $10.09 and offers an 11.5% dividend yield.
Access Investment Management LLC Has $456,000 Stock Holdings in Perrigo Company plc $PRGO
Access Investment Management LLC significantly reduced its stake in Perrigo Company plc (NYSE:PRGO) by 87.3% in the first quarter, now holding 42,500 shares valued at $456,000. Despite this, other institutional investors increased their positions, and analysts have a consensus "Hold" rating with an average target price of $19.33 for Perrigo. The company recently reported its quarterly earnings, beating estimates, and announced a quarterly dividend of $0.29 per share.
Perrigo Co. PLC stock underperforms Friday when compared to competitors
Perrigo Co. PLC (PRGO) stock fell 1.94% on Friday, closing at $10.11, despite an overall positive trading session for the broader market. This marks the second consecutive day of losses for the company, while the S&P 500 and Dow Jones Industrial Average both saw gains.
Perrigo declares $0.29 quarterly dividend, payable Sept. 15 By Investing.com
Perrigo Company plc (NYSE:PRGO) has announced a quarterly dividend of $0.29 per share, payable on September 15, 2026, to shareholders of record as of August 28, 2026. This dividend annualizes to $1.16 per share. The company, which is a consumer self-care products provider, made this announcement via a press release.
Perrigo declares $0.29 quarterly dividend, payable Sept. 15
Perrigo Company plc (NYSE:PRGO) has announced a quarterly dividend of $0.29 per share, to be paid on September 15, 2026, to shareholders of record as of August 28, 2026. This translates to an annualized dividend of $1.16 per share. The company, a consumer self-care products provider, made this announcement via a press release statement.
Perrigo Company plc (NYSE:PRGO) to Issue Quarterly Dividend of $0.29
Perrigo Company plc (NYSE:PRGO) announced a quarterly dividend of $0.29 per share, payable September 15th to shareholders of record on August 28th. This represents an annualized dividend of $1.16 and an 11.2% yield. The company has consistently increased its dividend for 23 consecutive years, with analysts expecting future earnings to sufficiently cover the payout.
Perrigo Company plc (NYSE:PRGO) Receives Average Recommendation of "Hold" from Analysts
Analysts have given Perrigo Company plc (NYSE:PRGO) an average "Hold" recommendation, with an average 12-month price target of $19.33. The company's recent quarterly earnings beat estimates but revenue declined year-over-year. Institutional investors and hedge funds own a significant portion of its stock.
RBF Capital LLC Takes Position in Perrigo Company plc $PRGO
RBF Capital LLC has acquired a new position in Perrigo Company plc (NYSE:PRGO), purchasing 180,000 shares valued at approximately $1.93 million. This acquisition makes RBF Capital LLC the owner of 0.13% of Perrigo's stock, contributing to the 95.91% institutional ownership of the company. Perrigo recently reported quarterly EPS of $0.43, surpassing estimates, though revenue declined by 7.2% year-over-year.
First Trust Advisors LP Grows Stock Holdings in Perrigo Company plc $PRGO
First Trust Advisors LP significantly increased its stake in Perrigo Company plc (NYSE:PRGO) by acquiring an additional 832,686 shares, bringing its total holdings to 1.50 million shares valued at approximately $16.1 million. Despite this, analyst sentiment remains cautious with a consensus "Hold" rating and a price target of $19.33, even though Perrigo recently beat quarterly EPS estimates. The company's shares opened near their 52-week low, and institutional investors collectively own 95.91% of PRGO stock.
BlackRock (PRGO holder) discloses 20.99M-share Perrigo stake on Schedule 13G/A
BlackRock, Inc. has filed an amended Schedule 13G/A, revealing a beneficial ownership of 20,988,733 shares of Perrigo Company plc common stock, which represents 15.2% of the class. The filing indicates BlackRock holds sole voting power over 20,758,891 shares and sole dispositive power over all 20,988,733 shares, with no shared powers. Notably, iShares Core S&P Small-Cap ETF, associated with BlackRock, holds more than 5% of Perrigo's outstanding common stock.
Perrigo executives set for Aug. 12 webcast at 10:30 a.m.
Perrigo (NYSE: PRGO) announced that its Interim President and CEO, Albert Manzone, and CFO, Eduardo Bezerra, will present at the Canaccord 46th Annual Growth Conference on Wednesday, August 12, at 10:30 AM EDT. The presentation will be webcast live on the company's investor relations website. Perrigo is a leading self-care company specializing in over-the-counter health and wellness products in North America and Europe.
Perrigo to Present at the Canaccord 46th Annual Growth Conference
Perrigo Company plc announced that its Interim President and CEO, Albert Manzone, and CFO, Eduardo Bezerra, are scheduled to present at the Canaccord 46th Annual Growth Conference. The presentation will take place on Wednesday, August 12th, at 10:30 AM EDT. A webcast of the event will be available on the Perrigo investor relations website.
Perrigo Company PLC (PRGO) Valuation: PE, PB & Fair Value Analysis
This article provides a valuation analysis of Perrigo Company PLC (PRGO), noting its current valuation score is 8.65, ranking 75th in the Pharmaceuticals industry. The article highlights the company's current P/E ratio and mentions that relevant data for P/B, P/S, and P/CF ratios have not yet been disclosed by the company. It indicates that the valuation score was updated on July 28, 2026.
Perrigo to Present at the Canaccord 46th Annual Growth Conference
Perrigo Company plc announced that Interim President and CEO Albert Manzone and CFO Eduardo Bezerra will present at the Canaccord 46th Annual Growth Conference on August 12th at 10:30 AM EDT. The presentation will be webcast live on the company's investor relations website. Perrigo, a leading self-care company, emphasized its focus on high-quality health and wellness solutions in North America and Europe, leveraging both store brand private labels and leading brands.
Perrigo Co. PLC stock outperforms competitors on strong trading day
Perrigo Co. PLC (PRGO) saw its stock advance 1.58% to $10.30 on Tuesday, outperforming the broader market. This gain occurred during a favorable trading session where the S&P 500 Index and Dow Jones Industrial Average also rose. It marked the stock's second consecutive day of gains.
PRGO|Perrigo Company PLC|Price:10.130|Chg%:+0.040
This article provides a comprehensive stock analysis of Perrigo Company PLC (PRGO), highlighting its relatively healthy fundamentals, high growth potential, and fair valuation within the Pharmaceuticals industry. While institutional ownership is very high and analysts largely rate it as "Hold," the stock price is expected to trend down in the medium term. The report details the company's strengths, risks, and its "TradingKey Stock Score," along with a peer comparison.
Perrigo Company PLC (PRGO) Income Statement
This article presents the quarterly and annual income statements for Perrigo Company PLC (PRGO), offering detailed financial data including total revenue, cost of revenue, operating expenses, and net income over several years. It provides investors with insights into the company's financial performance and operational efficiency. The data helps analyze growth trends and profitability by comparing metrics year-over-year.
Gabelli Funds LLC Has $9.60 Million Stock Position in Perrigo Company plc $PRGO
Gabelli Funds LLC increased its stake in Perrigo Company plc (NYSE:PRGO) by 29.8% to $9.60 million in the first quarter, now holding 893,359 shares. Despite reporting quarterly EPS of $0.43 which beat estimates, Perrigo's revenue declined 7.2% year over year, and the company posted a negative net margin. Analysts maintain a consensus "Hold" rating for PRGO with a price target of $19.33, while the stock recently traded around $10.08.
Perrigo Company PLC (PRGO) Cash Flow
This article provides a detailed overview of Perrigo Company PLC's cash flow statement, including operating, investing, and financing activities. It presents both annual and quarterly financial data for various cash flow components, helping users assess the company's financial soundness. The article also includes a FAQ section defining different types of cash flow and answering specific questions about Perrigo's cash flow performance.
Gamco Investors INC. ET AL Buys 320,081 Shares of Perrigo Company plc $PRGO
Gamco Investors INC. ET AL significantly increased its stake in Perrigo Company plc (NYSE:PRGO) during the first quarter by purchasing 320,081 additional shares, bringing their total holding to 1,397,866 shares valued at approximately $15.0 million. The article notes that analysts currently have a "Hold" rating on Perrigo, with a consensus price target of $19.33, despite the company reporting better-than-expected EPS but lower-than-anticipated revenue which also declined year over year. Perrigo also announced a quarterly dividend of $0.29 per share, resulting in an attractive annualized yield of 11.5%.
Perrigo Company PLC (PRGO) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution
This article from TradingKey provides a revenue breakdown for Perrigo Company PLC (PRGO), detailing its business segments and regional contributions. As of FY2025, Contract Manufacturing accounted for 6.37% of revenue, with the United States contributing 59.72% and Europe 38.00% of regional revenue. The data is presented in USD and was last updated on April 6th.
Perrigo Company PLC (PRGO) Technical Analysis: Support, Resistance, Indicators & Moving Averages
This article provides a technical analysis of Perrigo Company PLC (PRGO), detailing its current price momentum score of 3.83, ranking it 80th in the Pharmaceuticals industry. It highlights the stock's trading range between resistance at 11.27 and support at 9.24, suggesting suitability for range-bound swing trading. The analysis also includes indicator values such as MACD, RSI, and moving averages, which collectively point to a "Neutral" signal for the stock based on current technical indicators.
PRGO|Perrigo Company PLC|Price:10.090|Chg%:-0.010
Perrigo Company PLC (PRGO) is trading at $10.090, down 0.10%, with a market cap of $1.39 billion. Analysts rate the stock as "Hold" with a target price of $15.50, suggesting a potential upside of 48.04%. The company's fundamentals are robust, despite its stock price showing a downward trend in the medium term, and its valuation is considered fairly valued within the Pharmaceuticals industry.
Form 4 PERRIGO Co plc For: 24 July By Investing.com
This article reports on a Form 4 filing for PERRIGO Co plc, dated July 24. A Form 4 is a document that must be filed with the U.S. Securities and Exchange Commission (SEC) whenever there is a change in the ownership of company stock by company insiders. The filing likely details transactions involving PERRIGO Co plc shares by its directors or officers.
Perrigo Company plc (PRGO) Stock Price, News, Quote & History
This Yahoo Finance page provides detailed stock information for Perrigo Company plc (PRGO), including its current stock price, recent trading activity, key financial metrics, and performance over various periods. It also offers an overview of the company's business segments and products, analyst insights, and comparisons with similar companies in the specialty and generic drug manufacturing industry.
Perrigo to Release Second Quarter 2026 Financial Results on August 5, 2026
Perrigo Company plc (NYSE: PRGO) announced it will release its second quarter 2026 financial results on Wednesday, August 5, 2026. An earnings conference call will be held at 8:30 a.m. EST, hosted by Interim President and CEO Albert Manzone and CFO Eduardo Bezerra, with webcast and dial-in options available to investors. A replay of the call will also be accessible for a limited time.
PRGO: Perrigo Company plc Latest Stock Price, Analysis, News and Trading Ideas
This page provides current stock information for Perrigo Company plc (PRGO), including its latest stock price, pre-market data, market capitalization, volume, and upcoming earnings date. It also lists recent news articles related to Perrigo and other trending stocks like GOOGL, SMCI, and RKLB.
